Research Labs

and/or
180 Faculty Members found
The Craig Thompson Lab
Cancer Biology & Genetics Program
Craig Thompson studies molecular signaling pathways that regulate nutrient uptake and the role these pathways play in the regulation of cell growth and survival.
The Meng-Fu Bryan Tsou Lab
Cell Biology Program
Cell biologist Meng-Fu Bryan Tsou studies cell cycle control of centrosome duplication and degeneration, as well as cilia assembly and disassembly.
Human Oncology & Pathogenesis Program
The Tulpule lab studies how cells compartmentalize critical cellular processes with a focus on biomolecular condensates in cancer.
Immuno-Oncology Program
The Vardhana Lab studies how nutrient availability, uptake and metabolism regulates host immune responses during cancer development and immunotherapy.
Memorial Hospital Research Laboratories
Associate Attending Computer Scientist Harini Veeraraghavan's lab develops and translates new AI and machine learning tools diagnosing and personalizing cancer treatments through automated segmentation of normal tissues and tumors applied to radiation treatment automation, early predicting treatment response and toxicity prediction, and longitudinal tumor treatment response monitoring from medical images.
The Andrea Ventura Lab
Cancer Biology & Genetics Program
Cancer biologist Andrea Ventura studies DNA structural rearrangements and non-coding RNAs in cancer and development.
Cell Biology Program
The laboratory investigates cellular lipid and energy metabolism, in particular the mechanisms and physiology of neutral lipid synthesis and storage in lipid droplets.
The Britta  Weigelt Lab
Memorial Hospital Research Laboratories
Molecular geneticist Britta Weigelt studies the genomics of gynecologic cancers and the use of circulating cell-free DNA for disease monitoring and the identification of therapy resistance mechanisms.
Memorial Hospital Research Laboratories
Physician-scientist Martin Weiser investigates the mechanisms underlying tumor spread and metastasis and how these mechanisms could be targeted.
Pictured: Wendel Lab
Cancer Biology & Genetics Program
Cancer biologist Hans-Guido Wendel pursues both disease-centered and basic discovery research. The disease focus is on lymphocyte malignancies and the basic science arm of the lab explores fundamental mechanisms that control aberrant mRNA translation programs in cancer. Work in these two research areas frequently intersects in surprising ways.